Insider Ledger
Evogene Ltd. (EVGN) insider buying and SEC filings
Evogene Ltd. · CIK 1574565
Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Agricultural Chemicals
- State of incorporation
- L3
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$694K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 4, 2026 | Purchase (code P) | Gabi Tarcic (Chief Development Officer) bought 1,129 shares at $0.6000 ($677), reported as a purchase (code P). New position of 1,129 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 11, 2026 | Purchase (code P) | Leon Recanati (Director) bought 460,000 shares at $0.6400 ($294K), reported as a purchase (code P). Holdings up 52% to 1,343,886 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| Aug 4, 2026 | Purchase (code P) | Leon Recanati (Director) bought 800,000 shares at about $0.5000 ($400K), reported as a purchase (code P). Holdings up 954% to 883,886 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
4 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EVGN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.